The Legislative Yuan approved the first reading of an amendment to a WTO agreement yesterday, which will allow Taiwanese pharmaceutical companies to make cheaper generic drugs for underdeveloped countries to combat fatal diseases such as HIV/AIDS, malaria and bird flu.
The WTO initiative, called Protocol Amending the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS), will make it easier for poorer countries to import cheaper generic drugs made under compulsory licensing if they are unable to manufacture the medicines themselves.
The amendment to TRIPS Article 31 regarding compulsory licensing, which was approved by WTO member states in August 2005, authorizes pharmaceutical companies in WTO countries, if requested, to manufacture and export cheaper generic drugs to least developed countries, without having to pay the patent holders.
“Following the Cabinet’s approval of this amendment last month, the final approval from lawmakers will allow the government to report Taiwan’s TRIPS acceptance to the WTO Secretariat through Taiwan’s mission to WTO in Geneva,” said Wang Mei-hua (王美花), director-general of the Ministry of Economic Affairs’ Intellectual Property Office (IPO).
The WTO’s General Council has asked all member nations to obtain approval from their own lawmakers and to notify it no later than Dec. 31 next year. Once two-thirds of members have formally accepted it, the amendment will take effect in those states.
The IPO head said that final approval of the amendment could be settled in about two months.
“At present, 15 of the 151 WTO member states have notified the WTO of their acceptance, including the US, the EU, Japan, China, Australia and South Korea,” she said.
Wang said Taiwan will also have to revise its patent regulations to accommodate the new TRIPS regulations.
“The bureau has drafted a revision of the patent statute, which will also be reviewed by the legislature at some point,” she said.
Wang said that once the legal grounds for the amendment are established, Taiwan would be able to contribute more to the international community, particularly to poor countries that have little or no technological or financial ability to offer advanced medical treatment.
“With its advanced pharmaceutical ability, Taiwan could offer assistance especially to its 23 diplomatic alliances, most of which are underdeveloped countries,” she said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day